MARAMARA Holdings

On September 8, 2026, Salman Khan, the Company’s Chief Financial Officer, entered into a 10b5-1 Plan. Mr. Khan’s 10b5-1 Plan provides for the potential sale of up to 192,000 shares of the Company’s common stock between the first potential sale date on January 4, 2027 and the expiration of the 10b5-1 Plan on December 31, 2027. Mr. Khan’s existing 10b5-1 Plan will expire on December 31, 2026.

On August 7, 2026, Vicki Mealer-Burke, a member of the Board, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). Ms. Mealer-Burke’s 10b5-1 Plan provides for the potential sale of up to 41,380 shares of the Company’s common stock between the first potential sale date on February 1, 2027 and the expiration of the 10b5-1 Plan on April 30, 2027.

On June 9, 2026, Douglas Mellinger, the Lead Independent Director on the Company’s Board of Directors, entered into a 10b5-1 Plan. Mr. Mellinger’s 10b5-1 Plan provides for the potential sale of up to 15,000 shares of the Company’s common stock between the first potential sale date on September 10, 2026 and the expiration of the 10b5-1 Plan on November 30, 2027. Mr. Mellinger’s prior 10b5-1 Plan expired on June 30, 2026.

On June 9, 2026, Fred Thiel, the Company’s Chief Executive Officer and Chairman of the Board of Directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). Mr. Thiel’s 10b5-1 Plan provides for the potential sale of up to 330,060 shares of the Company’s common stock between the first potential sale date on October 1, 2026 and the expiration of the 10b5-1 Plan on September 30, 2027. Mr. Thiel’s existing 10b5-1 Plan will expire on September 30, 2026.

On February 6, 2026, Vicki Mealer-Burke, a member of the Company’s board of directors, terminated a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, which was adopted on September 9, 2025 for the sale of 21,551 shares of the Company’s common stock.

On November 24, 2025, Jay Leupp, a member of the Company’s board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). Mr. Leupp’s 10b5-1 Plan provides for the potential sale of up to 23,504 shares and gift of up to 3,000 shares of the Company’s common stock between April 1, 2026 and the expiration of the 10b5-1 Plan on March 31, 2027.

On September 12, 2025, Zabi Nowaid, General Counsel and Corporate Secretary, entered into a 10b5-1 Plan. Mr. Nowaid’s 10b5-1 Plan provides for the potential sale of up to 115,000 shares of the Company’s common stock between the first potential sale date on December 17, 2025 and the expiration of the 10b5-1 Plan on December 31, 2026.

On September 11, 2025, Salman Khan, Chief Financial Officer, entered into a 10b5-1 Plan. Mr. Khan’s 10b5-1 Plan provides for the potential sale of up to 176,000 shares of the Company’s common stock between the first potential sale date on February 17, 2026 and the expiration of the 10b5-1 Plan on December 31, 2026. Mr. Khan’s existing 10b5-1 Plan will expire on December 31, 2025.

On September 9, 2025, Vicki Mealer-Burke, a member of the Company’s board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). Ms. Mealer-Burke’s 10b5-1 Plan provides for the potential sale of up to 21,551 shares of the Company’s common stock between the first potential sale date on February 2, 2026 and the expiration of the 10b5-1 Plan on April 30, 2026.

On May 28, 2025, Fred Thiel, Chief Executive Officer and Chairman of the Board, entered into a 10b5-1 Plan. Mr. Thiel’s 10b5-1 Plan provides for the potential sale of up to 357,565 shares of the Company’s common stock between the first potential sale date on September 17, 2025 and the expiration of the 10b5-1 Plan on September 30, 2026.

On March 14, 2025, Salman Khan, Chief Financial Officer, entered into a 10b5-1 Plan. Mr. Khan’s 10b5-1 Plan provides for the potential sale of up to 69,465 shares of the Company’s common stock between the first potential sale date on June 12, 2025 and the expiration of the 10b5-1 Plan on December 31, 2025. Mr. Khan’s existing 10b5-1 Plan will expire on May 30, 2025.

On March 10, 2025, Jay Leupp, a member of the Company’s board of directors, entered into a 10b5-1 Plan. Mr. Leupp’s 10b5-1 Plan provides for the potential sale of up to 33,500 shares of the Company’s common stock between the first potential sale date on June 9, 2025 and the expiration of the 10b5-1 Plan on March 31, 2026. Mr. Leupp’s existing 10b5-1 Plan will expire on June 5, 2025.

On March 6, 2025, Douglas Mellinger, a member of the Company’s board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). Mr. Mellinger’s 10b5-1 Plan provides for the potential sale of up to 13,000 shares of the Company’s common stock between the first potential sale date on June 6, 2025 and the expiration of the 10b5-1 Plan on June 30, 2026. Mr. Mellinger’s existing 10b5-1 Plan will expire on May 13, 2025.

On June 18, 2024, Fred Thiel, Chief Executive Officer and Chairperson of the Board, entered into a 10b5-1 Plan. Mr. Thiel’s 10b5-1 Plan provides for the potential sale of up to 357,572 shares of the Company’s common stock between the first potential sale date on September 16, 2024 and the expiration of the 10b5-1 Plan on September 16, 2025.

On June 18, 2024, Salman Khan, Chief Financial Officer, entered into a 10b5-1 Plan. Mr. Khan’s 10b5-1 Plan provides for the potential sale of up to 66,800 shares of the Company’s common stock between the first potential sale date on September 16, 2024 and the expiration of the 10b5-1 Plan on December 31, 2024.

On June 5, 2024, Jay Leupp, a member of the Company’s board of directors, entered into a 10b5-1 Plan. Mr. Leupp’s 10b5-1 Plan provides for the potential sale of up to 31,200 shares of the Company’s common stock between the first potential sale date on September 4, 2024 and the expiration of the 10b5-1 Plan on June 5, 2025.

On May 13, 2024, Doug Mellinger, a member of the Company’s board of directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). Mr. Mellinger’s 10b5-1 Plan provides for the potential sale of up to 10,000 shares of the Company’s common stock between the first potential sale date on August 12, 2024 and the expiration of the 10b5-1 Plan on May 13, 2025.